Richard Radnovich, DO
Sports Medicine · Boise, IDNPI 1407944655
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,953 of the $4,354 with a category attached, or 67.8%. 11 manufacturers reported payments, led by Pacira Pharmaceuticals Incorporated at 49.5% of the total.
Across 63 payments — averaging $69.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$2K
- MDD US Operations, LLC$2K
- Pfizer$181
- AbbVie$119
- Boehringer Ingelheim$111
- Biodelivery Sciences International, Inc.$108
- plus $156 from 5 others
Across 155 payments — averaging $3240.89 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Seikagaku Corporation$227K
- Scilex Pharmaceuticals Inc.$96K
- GRT US Holding, Inc.$61K
- GSK$37K
- Gilead$19K
- Exeltis, USA Inc.$19K
- plus $44K from 7 others
What the payments were for
- Travel & lodging$2,95368%
- Food & beverage$1,40132%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 6 | $2,158 |
| MDD US Operations, LLC | 16 | $1,521 |
| Pfizer | 27 | $181 |
| AbbVie(2 entities) | 3 | $119 |
| Boehringer Ingelheim | 1 | $111 |
| Biodelivery Sciences International, Inc. | 3 | $108 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $55 |
| Eisai Inc. | 2 | $40 |
| Amgen | 2 | $35 |
| Acelrx Pharmaceuticals, Inc. | 1 | $13 |
| Lilly USA, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Zilretta$1,987
- Lucemyra/Lofexidine$1,038
- JARDIANCE$111
How this compares
$4,354 in reported general payments places this provider in the 80th percentile of 33 sports medicine providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other sports medicine in Boise
- Nathan GrimmBoise$23K
- Michael GustavelBoise$12K
- Jennifer MillerBoise$9K
- Darin JurgensmeierBoise$3K
- Kirk LewisBoise$2K
- Tobias GoponBoise$377
- Scot ScheffelBoise$300
- Justin McCoyBoise$291
- Alejandro HomaechevarriaBoise$184
- Tin VuongBoise$114
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.